A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Clinical trial NCT06679036 · RECRUITING

Trial details

NCT number: NCT06679036
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Unresectable or Metastatic Breast Cancer

Start date: 2025-01-21
Primary completion: 2026-10-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.